CPRIT announces new grants to support variety of cancer-fighting research projects in Texas

NewsGuard 100/100 Score

The Cancer Prevention and Research Institute of Texas (CPRIT) today announced more than $85 million in funding to support 75 new scientific research projects and scientific recruits to support a variety of cancer-fighting efforts in Texas. These new awards bring the total tally of funded grants to 502, amounting to nearly $841 million since the Institute opened its doors in 2009.

The 11 new CPRIT Scholar in Cancer Research awards will potentially bring investigators from institutions such as Harvard, Memorial Sloan-Kettering Cancer Center and Dana-Farber Cancer Institute to the state.

"As we begin our fourth year, we're taking stock of lessons learned this year and improving our operations to emerge a stronger organization, while continuing our grant approval processes to ensure that worthy projects move forward," said Bill Gimson, CPRIT executive director. "The projects funded today touch on many aspects of research so that we can tackle cancer on a number of fronts."

Highlights among the funded projects include:

  • Development of a "smart scalpel," or ultrafast laser technology, to maximize precision in cutting away malignant growths while minimizing damage to surrounding, healthy tissue
  • The expansion and enhancement of resources to provide expertise in preparing cells that are used for cancer treatment to researchers across the state
  • A study comparing the outcomes of two types of radiation treatment among children with brain cancer
  • An investigation into the use of a light-driven system to turn "on" or "off" the expression of proteins thought to play a role in cancer development, in lieu of less targeted chemical methods

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases